US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Apr 1, 2026 (5 months ago)

fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP deviations.

What was recalled

fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL), 250 mL bag, wells pharma of Houston, NDC 73702-202-03.

Recalling firm
Wells Pharma of Houston LLC
NDC code
73702-202-03
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0504-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all